My name is Kelsey Campbell, I’m a second-year graduate student in the department of neuroscience, and I’m working in Dr. Daniel Lee’s lab studying the effects of impacted nutrient signaling in Alzheimer’s disease (AD).
The National Institutes of Health (NIH)awarded the University of Kentucky a prestigious center grant to share its expertise and lead national efforts to build diverse academic research environments.
Nearly three years ago, the University of Kentucky College of Medicine launched the Alliance Research Initiative to promote collaboration and mentorship through interdisciplinary research teams. With members spanning across UK departments and colleges, these teams were established to address Kentucky’s most urgent health needs.
The 2023 American Society for Neurochemistry (ASN) annual meeting is set to take place March 18 to March 22 in downtown Lexington.
Throughout March, the University of Kentucky is spotlighting Women Making History during Women’s History Month. These women are leading their fields of research and impacting the lives of Kentuckians.
Feb. 28 is international Rare Disease Day. Kentucky has surprisingly high rates — almost 10 times the national average — of a rare condition called Moyamoya syndrome, which causes the internal carotid arteries in the brain to become narrow or blocked.
The University of Kentucky College of Medicine is pleased to announce the faculty, staff, and learners who were winners of the annual Mission, Vision, Pillar, and Enabler Awards.
The UK College of Medicine is excited to welcome Gurpreet Dhaliwal, MD, as the visiting professor delivering this year’s Alpha Omega Alpha (AOA) Humanities Lecture.
The University of Kentucky is a site for the groundbreaking AHEAD study, the first-ever clinical trial to test the effect of a promising drug known as lecanemab. Just a few weeks ago the U.S.
The Pat Summitt Foundation presented a $25,000 grant to the University of Kentucky's Sanders-Brown Center on Aging (SBCoA)during the UK women’s basketball game against Auburn University on Thursday evening. The center is one of the nation’s top centers on aging, with a goal to preserve brain health and slow the progression of dementia.
The University of Kentucky’s ninth annual Healthy Hearts for Women Symposium will bring in nationally recognized experts to raise awareness about the dangers of heart disease and educate attendees on prevention techniques.
My name is Jessica Gebhardt, and I am a graduate student in Dr. Josh Morganti’s Lab studying the effects of dysregulated neuroinflammation following traumatic brain injury (TBI). TBI has personally impacted me and my family, and as a result I have been interested in furthering my understanding of the mechanisms underlying the injury for many years.
The University of Kentucky is a site for the groundbreaking AHEAD study, the first-ever clinical trial to test the effect of lecanemab (investigational antibody) in people who have no cognitive symptoms of Alzheimer’s disease (AD), but in whom biomarker tests indicate amyloid is present in the brain, known as “preclinical” AD.
Donna Wilcock, PhD, wears many hats at the University of Kentucky, all of which are roles that help advance education and research in the Commonwealth, particularly in the realm of Alzheimer’s disease. Dr. Wilcock is assistant dean for biomedicine at the UK College of Medicine, as well as associate director of Sanders-Brown Center on Aging. She is also the Robert P.
Our College of Medicine community,
During Indigenous Peoples’ Month, the UK College of Medicine is highlighting historical figures who paved the way for an equitable future in medicine.
“For some reason, I really wanted fruit or savory food when I was going through treatment. Spicy, savory, salty food — that helped with my appetite,” recalls University of Kentucky chemistry doctoral student Yueming “Ronnie” Wu.
The University of Kentucky’s (UK) Sanders-Brown Center on Aging (SBCoA) will host its 12th annual Markesbery Symposium on Aging and Dementia this weekend. The event is named in honor and memory of the late William R. Markesbery, MD, founding director of the Sanders-Brown Center on Aging and Alzheimer's Disease Research Center.
The University of Kentucky Sanders-Brown Center on Aging will hold the 12th annual Markesbery Symposium on Aging and Dementia on Nov. 18 and 19. The scientific session will take place from 11 a.m. until 4:30 p.m. Friday, Nov. 18, in the Lee T. Todd Building.
Donna Wilcock, PhD, of the University of Kentucky’s Sanders-Brown Center on Aging (SBCoA) was awarded a $1.7 million National Institutes of Health grant for her lab’s exploration of adverse effects of two new Alzheimer’s disease drugs — aducanumab and lecanemab — which have been shown to slow the progression of cognitive decline.